Long non-coding rna and chemoresistance in bladder cancer – a mini review.
Nenhuma Miniatura disponível
Data
2022
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Bladder cancer is the 10th most common cancer worldwide. It is a heterogeneous disease,
comprising several tumor subtypes with differences in histology, genomic aberrations, prognosis and sensitivity to anti-cancer treatments. Although the treatment of bladder cancer is
based tumor classifications and gradings, patients have different clinical response. In recent
years, long non-coding RNAs (lncRNAs) were associated with bladder cancer chemoresistance. Thus, lncRNAs seem to be promising targets in treatment of bladder cancer. This
review highlights the recent findings concerning lncRNAs and their relevance to the chemoresistance of bladder cancer. This may provide a basis for exploiting more robust therapeutic approaches in the future.
Descrição
Palavras-chave
Bladder cancer, Chemoresistance
Citação
LIMA, A. P. B.; SILVA, G. N. da. Long non-coding rna and chemoresistance in bladder cancer – a mini review. Cancer Investigation, v. 41, n. 2, p. 164–172, nov. 2022. Disponível em: <https://www.tandfonline.com/doi/epdf/10.1080/07357907.2022.2146703?needAccess=true&role=button>. Acesso em: 01 ago. 2023.